These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

83 related articles for article (PubMed ID: 11223874)

  • 1. Increased serum angiotensin converting enzyme activity in diabetes mellitus is not a uniform finding.
    Bor MV
    Cell Biochem Funct; 2001 Mar; 19(1):69-71, 73-4. PubMed ID: 11223874
    [No Abstract]   [Full Text] [Related]  

  • 2. [Angiotensin converting enzyme in the blood and lungs in experimental diabetes].
    Huskić J; Filipović N
    Med Arh; 1989; 43(1):41-3. PubMed ID: 2560523
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Increased serum angiotensin-converting enzyme activity and plasma angiotensin II levels during pregnancy and postpartum in the diabetic rat.
    van Dijk DJ; Boner G; Giler S; Erman A
    J Renin Angiotensin Aldosterone Syst; 2001 Sep; 2(3):193-8. PubMed ID: 11881122
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Genetically increased angiotensin I-converting enzyme level and renal complications in the diabetic mouse.
    Huang W; Gallois Y; Bouby N; Bruneval P; Heudes D; Belair MF; Krege JH; Meneton P; Marre M; Smithies O; Alhenc-Gelas F
    Proc Natl Acad Sci U S A; 2001 Nov; 98(23):13330-4. PubMed ID: 11687636
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Renal angiotensin-converting enzyme localization in diabetic rats and the effect of low protein diet.
    Mizuiri S; Kobayashi M; Nakanishi T; Yoshikawa H; Miyagi M; Tanegashima M; Sakai K; Hayashi I; Fushimi T; Hasegawa A
    Nephron; 1997; 76(2):186-91. PubMed ID: 9200410
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Identification of angiotensin converting enzyme 2 in the rodent retina.
    Tikellis C; Johnston CI; Forbes JM; Burns WC; Thomas MC; Lew RA; Yarski M; Smith AI; Cooper ME
    Curr Eye Res; 2004 Dec; 29(6):419-27. PubMed ID: 15764086
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Glomerular renin angiotensin system in streptozotocin diabetic and Zucker diabetic fatty rats.
    Leehey DJ; Singh AK; Bast JP; Sethupathi P; Singh R
    Transl Res; 2008 Apr; 151(4):208-16. PubMed ID: 18355768
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Relationship between serum angiotensin I-converting enzyme activity and diabetic nephropathy in patients with type II diabetes].
    Liao L; Lei M; Han X; Chen H; Fan C
    Hunan Yi Ke Da Xue Xue Bao; 1999; 24(3):263-6. PubMed ID: 12016801
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Chronic salt loading and cardiovascular-associated changes in experimental diabetes in rats.
    Maeda C; Schaan B; Oliveira E; Oliveira V; De Angelis K; Irigoyen M
    Clin Exp Pharmacol Physiol; 2007 Jul; 34(7):574-80. PubMed ID: 17581211
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Serum angiotensin-converting enzyme: elevations in diabetes mellitus.
    Lieberman J; Sastre A
    Ann Intern Med; 1980 Dec; 93(6):825-6. PubMed ID: 6255846
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Kinins are involved in the antiproteinuric effect of angiotensin-converting enzyme inhibition in experimental diabetic nephropathy.
    Tschöpe C; Seidl U; Reinecke A; Riester U; Graf K; Schultheiss HP; Hilgenfeldt U; Unger T
    Int Immunopharmacol; 2003 Mar; 3(3):335-44. PubMed ID: 12639811
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Angiotensin-converting enzyme 2 and the kidney.
    Soler MJ; Wysocki J; Batlle D
    Exp Physiol; 2008 May; 93(5):549-56. PubMed ID: 18223023
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Increased aldosterone levels in a model of type 2 diabetes mellitus.
    Fredersdorf S; Endemann DH; Luchner A; Heitzmann D; Ulucan C; Birner C; Schmid P; Stoelcker B; Resch M; Muders F; Riegger GA; Weil J
    Exp Clin Endocrinol Diabetes; 2009 Jan; 117(1):15-20. PubMed ID: 18726873
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Impairment of proteolytic activity in isolated glomeruli and tubules in experimental diabetic nephropathy.
    Paczek L; Soin J; Bartlomiejczyk I; Królak R; Lao M; Gradowska L; Heidland A
    Clin Nephrol; 1996 Oct; 46(4):258-60. PubMed ID: 8905211
    [No Abstract]   [Full Text] [Related]  

  • 15. Correlates of ACE activity in macroalbuminuric type 2 diabetic patients treated with chronic ACE inhibition.
    Nikzamir A; Nakhjavani M; Esteghamati A; Rashidi A
    Nephrol Dial Transplant; 2008 Apr; 23(4):1274-7. PubMed ID: 17986476
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Reduced pulmonary endothelium-bound angiotensin converting enzyme activity in diabetic rabbits.
    McCloud LL; Parkerson JB; Zou L; Rao RN; Catravas JD
    Vascul Pharmacol; 2004; 41(4-5):159-65. PubMed ID: 15607499
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Differential effects of RAS inhibitors associated with ACE gene polymorphisms in type 2 diabetic nephropathy.
    Seki N; Hashimoto N; Suzuki Y; Yagui K; Saito Y
    Diabetes Res Clin Pract; 2006 May; 72(2):135-41. PubMed ID: 16290123
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Serum angiotensin converting enzyme activity in type 2 (non-insulin-dependent) diabetic patients with chronic glomerulonephritis.
    Ninomiya Y; Arakawa M
    Diabetes Res; 1989 Jul; 11(3):121-4. PubMed ID: 2560690
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Angiotensin-converting enzyme activity in dehydrated rats].
    Huskić J; Plazanić D; Huskić G; Ostojić Lj; Martinović S
    Srp Arh Celok Lek; 1992; 120(11-12):321-3. PubMed ID: 1340641
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Tumor necrosis factor-alpha gene expression in diabetic nephropathy: relationship with urinary albumin excretion and effect of angiotensin-converting enzyme inhibition.
    Navarro JF; Milena FJ; Mora C; León C; Claverie F; Flores C; García J
    Kidney Int Suppl; 2005 Dec; (99):S98-102. PubMed ID: 16336586
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.